Penn Medicine Abramson Cancer Center


 

Penn Medicine Updates on the KEYNOTE-716 Trial: DMFS With Pembro vs. Placebo as Adjuvant Therapy in Stage IIB/C Melanoma

52 views
July 14, 2022
Comments 0
Login to view comments. Click here to Login